Allianz Asset Management GmbH - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$947,793
-75.5%
23,100
-78.7%
0.00%
-71.4%
Q1 2023$3,868,784
-0.1%
108,248
+5.6%
0.01%
-12.5%
Q4 2022$3,870,934
+202.9%
102,487
+254.9%
0.01%
+166.7%
Q3 2022$1,278,000
+53.4%
28,880
+28.4%
0.00%
+200.0%
Q2 2022$833,000
-72.5%
22,497
-72.5%
0.00%
-50.0%
Q1 2022$3,031,000
+21.7%
81,8300.0%0.00%0.0%
Q4 2021$2,491,000
+276.9%
81,830
+315.2%
0.00%
+100.0%
Q3 2021$661,000
-15.9%
19,7100.0%0.00%0.0%
Q2 2021$786,000
-49.8%
19,710
-43.4%
0.00%
-50.0%
Q1 2021$1,566,000
-20.5%
34,8440.0%0.00%0.0%
Q4 2020$1,971,000
+698.0%
34,844
+731.2%
0.00%
Q2 2020$247,000
+4.7%
4,192
-16.0%
0.00%
Q1 2020$236,000
-35.9%
4,992
-18.1%
0.00%
Q4 2019$368,000
-4.2%
6,092
-4.9%
0.00%
Q3 2019$384,000
+1.9%
6,407
+9.3%
0.00%
Q2 2019$377,000
-56.7%
5,863
-45.4%
0.00%
-100.0%
Q1 2019$871,000
-70.4%
10,733
-80.6%
0.00%
-66.7%
Q4 2018$2,944,000
-3.9%
55,243
-7.0%
0.00%0.0%
Q3 2018$3,063,000
+23.8%
59,3800.0%0.00%
+50.0%
Q2 2018$2,474,000
-5.5%
59,3800.0%0.00%
-33.3%
Q1 2018$2,618,000
-24.4%
59,380
-13.8%
0.00%0.0%
Q4 2017$3,465,00068,8800.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders